ABS Global v. Cytonome/St, LLC: Mootness and Preserving the Argument for Vacatur
By EsqSocial Corporation 19/01/21
In 2017, Cytonome filed suit in the Western District of Wisconsin (“the District Court”), accusing ABS of infringing six of its patents, including US Patent No. 8,529,161 (“the ’161 patent”). Subsequently, in October 2017, ABS filed for inter partes review (“IPR”) of the ’161 patent, and the Patent Trial and Appeal Board (“the Board”) issued a decision in April 2019 that invalidated certain claims of the ’161 patent while also finding that ABS had failed to demonstrate several other claims as...
By: Rothwell, Figg, Ernst & Manbeck, P.C.